Housing Interventions and Control of Asthma-Related Indoor Biologic Agents: A Review of the Evidence : Journal of Public Health Management and Practice

Secondary Logo

Journal Logo

Review of Housing Interventions

Housing Interventions and Control of Asthma-Related Indoor Biologic Agents

A Review of the Evidence

Krieger, James MD, MPH; Jacobs, David E. PhD, CIH; Ashley, Peter J. DrPH; Baeder, Andrea MPH; Chew, Ginger L. ScD; Dearborn, Dorr MD, PhD; Hynes, H. Patricia MA, MS; Miller, J. David PhD; Morley, Rebecca MSPP; Rabito, Felicia PhD; Zeldin, Darryl C. MD

Author Information
Journal of Public Health Management and Practice 16(5):p S11-S20, September/October 2010. | DOI: 10.1097/PHH.0b013e3181ddcbd9


In this online-only supplement to the September/October 2010 issue, a correction must be noted for the article by James Krieger et al. In the section “House Dust Mites,” the unit of measure in the following sentences was published as μg/mg. That is incorrect. The unit of measure should be given as μg/g, as shown in the text below.

“A body of clinical and epidemiologic evidence suggests that exposure to Der p or Der f antigens at levels greater than 2 μg/g is associated with sensitization and above 10 μg/g with exacerbation of established asthma in mite-sensitized persons.9,10 These cut-points are often used to assess exposure risk in field studies. A recent survey found that more than 80% of homes in the United States have detectable levels of house dust mite allergen in the bedroom, 46% have levels above 2 μg/g, and 24% have levels above 10 μg/g.11

Journal of Public Health Management and Practice. 16(5):, September/October 2010.

Asthma is of great concern because its prevalence and morbidity have increased dramatically in the past 2 decades.1 Recent basic research suggests that asthma develops as a result of interactions between genes and environments.2 The contribution of environmental factors to the observed increase in asthma has been the focus of many investigations.37 Biologic agents figure prominently among environmental factors implicated in asthma morbidity, including allergens from cockroaches, rodents, dust mites, and fungi, in addition to respiratory irritants such as fungal cell wall components.4

Housing conditions are associated with exposure to these biologic agents. Excess moisture in a home supports the growth of mold and provides an environment favorable to dust mites, cockroaches, and rodents. Common sources of water and moisture in homes include structural membrane leaks, condensation, damp foundations and crawl spaces, inadequate ventilation, activities such as bathing and cooking, and unattended plumbing problems.7 Structural and plumbing deficiencies in a home provide entry points for pests, which are attracted by hidden food spills and garbage.8 Poorly maintained heating and ventilation can disburse allergen-containing dust throughout the home.

House Dust Mites

Dust mite allergens are the only class of inhalant allergens for which the National Academy of Sciences found sufficient evidence for a causal association between exposure and the development of asthma.4 Exposure to dust mite allergen is also associated with asthma exacerbations. A body of clinical and epidemiologic evidence suggests that exposure to Der p or Der f antigens at levels greater than 2 μg/mg is associated with sensitization and above 10 μg/mg with exacerbation of established asthma in mite-sensitized persons.9,10 These cut-points are often used to assess exposure risk in field studies. A recent survey found that more than 80% of homes in the United States have detectable levels of house dust mite allergen in the bedroom, 46% have levels above 2 μg/mg, and 24% have levels above 10 μg/mg.11


Cockroach allergens are an important cause of asthma exacerbations, particularly in deteriorated homes where cockroach infestation is most common.1214 Heavy infestations in homes may create reservoirs of allergen in carpets, rugs, and beds and in areas that are difficult to reach behind appliances and furniture.15 A detectable level of cockroach allergen is found in 63% of dwellings in the United States,16 and 10.2% of all dwellings have cockroach allergen levels above the asthma morbidity cut-point.17

Fungi (Mold) and Excessive Moisture

Epidemiologic and laboratory evidence links the presence of mold and moisture to poor health outcomes, such as upper respiratory tract symptoms, cough, wheeze, and other asthma symptoms.18 Although mold is associated with exacerbation of allergic rhinitis and allergic asthma in those people who are sensitized to mold, some components of mold can also elicit inflammation via nonallergic mechanisms.4,18,19 Fungal growth can result from excessive indoor moisture.17


The contribution of exposure to rodents to allergic conditions was first described in studies of laboratory animal workers caring for mice and rats.20,21,22 More recent research has shown that allergens from these rodents are present in homes and are associated with asthma morbidity.23 Detectable levels of mouse allergen are found in 82% of dwellings in the United States.24 The National Cooperative Inner City Asthma Study found that 95% of all homes assessed had detectable mouse allergen in at least 1 room, suggesting that mouse allergens are widely distributed in inner-city homes.25 Chew et al26 observed that mouse allergens were common in low-income, inner-city apartments even when sightings were not reported.

Interventions Reviewed

The literature search and review methods are described in more detail in a companion article in this series by Jacobs et al.27 In brief, the panel sought to identify interventions that are effective in improving asthma outcomes by reducing exposure to indoor biologic asthma triggers. The panel searched the literature for publications describing interventions as well as the Web for guidelines. Titles and abstracts of all retrieved articles were read and each relevant articles was reviewed and abstracted into standard study summary templates by 2 panel members and scored as to the degree of impact and study quality. Panel members as a group reviewed the scoring and agreed-upon classification of each intervention as having sufficient evidence effectiveness and ready for implementation, needing more field testing but promising, promising but needing formative research, and ineffective.

An effective intervention results in improvements in health or leads to changes in behaviors or other factors that have been previously shown to result in better health.28 The definition of “sufficient evidence” of effectiveness is based on the Centers for Disease Control and Prevention Community Guide, which bases its ratings on intervention studies.28 In addition, we deemed an intervention to have sufficient evidence if the combination of intervention studies (on their own insufficient for meeting the guide criteria), other expert panel recommendations, and strong epidemiologic evidence of association between exposure and health outcomes was convincing. We did not limit the studies reviewed to randomized controlled trials, because the likelihood of harm from the types of interventions under consideration is low, suggesting that the level of evidence need not be as rigorous, and because this is an emerging and rapidly developing field. In short, the recommendations are based on existing evidence and not the best possible evidence.

For this topic, a panel of subject matter experts reviewed the following 11 interventions:

  • multifaceted, tailored asthma interventions;
  • integrated pest management (IPM) to reduce pest exposure;
  • elimination of moisture intrusion and leaks and removal of moldy items;
  • improved insulation;
  • HEPA air filtration;
  • carpet cleaning and vacuuming;
  • ventilation and dehumidification;
  • one-time professional cleaning;
  • bedding encasement and/or sheet and/or upholstery cleaning alone;
  • acaricides as a single intervention; and
  • air cleaners releasing ozone.


Of the 11 interventions reviewed, 3 have sufficient evidence of effectiveness and are ready for implementation, 4 need more field testing but are promising, 1 is promising but needs formative research, and 3 are ineffective.

Sufficient evidence

Three interventions were supported by sufficient evidence to warrant widespread implementation. The Figure depicts the relationships between these interventions and health outcomes.

Housing Interventions to Control Indoor Biologic Agents: Interventions Ready for Implementationa

Multifaceted, in-home, tailored interventions for asthma

Home-based interventions that use a multifaceted approach to help residents decrease exposure to multiple asthma triggers are effective in reducing exposure to triggers, decreasing asthma symptoms and short-term health care use, and improving quality of life. These interventions tailor activities to triggers found in an individual's home and/or to which the individual is sensitized. Interventions include home environmental assessment, education, use of mattress and pillow covers, use of HEPA (or equivalent) vacuums and HEPA air filters, smoking cessation and reduced environmental tobacco smoke exposure, cockroach and rodent management, minor repairs, and intensified household cleaning. The panel found that evaluations of this approach were well designed, had many subjects from appropriate populations, and identified statistically significant improvements.

The strongest evidence comes from studies examining the impact of interventions on control of existing asthma.5,2931 The Inner City Asthma Study was a large, multisite randomized trial that targeted interventions to reduce exposure to asthma triggers to which a child was sensitized. It showed a large and clinically significant reduction in asthma symptoms days and a modest and significant reduction in emergency department and urgent clinic use.29 Eggleston et al30 found that their in-home intervention reduced concentrations of airborne particulate matter and dustborne cockroach allergen and decreased daytime asthma symptoms but not other measures of morbidity. Krieger et al5 showed that home visits by community health workers to support families in decreasing exposure to asthma triggers led to significantly reduced use of urgent health services and to improved quality of life for caretakers. Carter and colleagues29 found that home visits also decreased short-term visits for asthma among children with dust mite allergy.

Other studies with important methodological limitations (such as large attrition rates and small sample size) did not find significant benefits from home interventions.32,33 Additional studies of the benefit of such interventions for reducing incidence of asthma among infants at high risk for it have yielded mixed but generally modest positive results.3436

The panel conclusion that multifaceted, in-home interventions are effective is consistent with a recent high-quality systematic review of the evidence completed for the Centers for Disease Control and Prevention Task Force on Community Preventive Services. On the basis of strong evidence of effectiveness for these interventions, the task force now recommends home-based, multicomponent, multitrigger interventions with an environmental focus for children with asthma.37 The conclusion is also supported by recent studies that were not available when this panel convened.38,39

Cockroach control through IPM

Integrated pest management is effective in reducing cockroach allergen and pesticides.30,40 It includes carefully assessing the presence and location of roaches, removing food sources through proper food storage and cleaning (in some cases, professional cleaning), educating residents, repairing structural defects that allow roaches to gain access, applying low-toxicity gel-bait pesticides as needed, and monitoring and continuing intervention until roaches are eliminated.

Four randomized controlled studies have demonstrated the effectiveness of IPM in reducing exposure to cockroaches.30,4143 Arbes et al43 conducted a 6-month study and found that roach allergen levels were significantly reduced in beds and kitchens. The levels in the beds dropped below the thresholds for both sensitization and exacerbation. Wang and Bennett41 showed a significantly greater decrease in roach counts with IPM than with gel bait alone. Miller and Meek42 found that IPM was initially more costly but also much more effective in reducing cockroaches than with traditional pesticide treatment. These 3 studies did not report on health outcomes. A study by Eggleston et al30 showed a modest benefit on clinical outcomes but was a multifaceted intervention that addressed other allergens besides cockroaches.

Additional research, using less rigorous methods, has also found IPM to be effective. For example, Levy and colleagues32 showed reduced cockroach allergen and improved clinical outcomes in a single-group pre-post study. McConnell and colleagues44 conducted a randomized trial of IPM methods that showed decreased cockroach counts and dust allergen levels in the IPM group relative to the control group. This trial also showed that intensive cleaning can significantly reduce allergen levels in homes with initially high levels. Clinical outcomes were not reported. Other studies45,46 have also demonstrated improvements, but their conclusions were weakened by small sample sizes, inclusion of multiple interventions in addition to IPM, lack of control groups, use of nonstandard, self-reported measures of cockroach exposure, or interventions that would be difficult to replicate.

Evidence of the effectiveness of IPM for reducing exposure to rodent allergens is less well developed. A small study showed no significant improvement in asthma symptoms or forced expiratory volume but did show a significant decline in mouse allergen levels.47 In conclusion, the evidence that IPM is effective in reducing exposure to cockroach allergens is quite strong, but further evaluation of its role in reducing exposure to other pests is needed.

Combined elimination of moisture intrusion and leaks and removal of moldy items

The panel believes there is enough evidence to begin implementation of interventions that combine elimination of moisture intrusion and leaks and removal of moldy items to reduce mold exposure and respiratory symptoms. The panel took into consideration the Institute of Medicine report,18 local (New York City)48 and international guidelines (World Health Organization,49 Finland,50 Canada19), and the studies evaluated in the following text. The recent World Health Organization report states that “although few intervention studies were available, their results show that remediation of dampness can reduce adverse health outcomes.”49 It is important to recognize that these interventions may not produce improvements in health in all individuals who are exposed to dampness and mold.

The panel reviewed several intervention studies, many of which were limited by small sample size, lack of control groups, or implementation in nonresidential settings. The largest study (164 homes) was a randomized controlled trial of visible mold eradication (with removal, fungicide application, and ventilation fan installation) among people with asthma. It reduced symptoms and medication use, although not peak flow variability.51 Another randomized trial52 had only 29 participants in the experimental group and 33 in the control group. Despite the small sample size, this housing remediation intervention showed improved asthma clinical outcomes. While it is not clear how much mold was in the homes of these studies before the intervention, both studies listed presence of mold as an inclusion criterion.

Several smaller studies have also suggested that interventions can decrease exposure to mold. One study examined the effect of prompt remediation after water intrusion in a single home and found decreased spore counts and resolution of allergic symptoms.53 A time-series study compared mold exposure and symptoms at a mold-contaminated school before and after remediation with a comparison school. The investigators found that prior to remediation, the contaminated school had higher mold levels and the children had more allergic and respiratory symptoms than the comparison school. These differences disappeared after intervention.54 A small uncontrolled study of moisture and mold control in 3 flood-damaged homes showed that mold (eg, spore and colony counts) and endotoxin increased significantly during renovation work and declined significantly following the removal of moldy items and a multistep cleanup process.55

Promising interventions that need more field evaluation

The panel identified 4 interventions—improved insulation, repeated dry-steam cleaning of carpets and upholstered furniture and repeated vacuuming, use of air cleaning devices, and moisture control through dehumidification (including improved general and local exhaust ventilation)—as promising interventions that need more field testing. Each of these interventions has been evaluated, but the evidence of effectiveness is not sufficient to recommend widespread implementation. Further evaluation in real-world settings is needed to determine generalizabilty and feasibility of replication.

Improved insulation

The panel found that a large, well-designed, randomized controlled trial of home insulation in New Zealand showed decreased moisture and mold exposure and improved general and respiratory health status.56 This promising finding should be replicated in different climate zones and settings as the next step toward wider implementation.

Repeated dry-steam cleaning and repeated vacuuming

The panel found that several studies of repeated cleaning and/or vacuuming showed these interventions to be promising but in need of more field testing. For example, a small study (11 homes) of intensive vacuuming and steam cleaning of carpeting and furnishings showed sustained reductions in concentration and load of mite allergen in dust relative to vacuuming alone. Both approaches decreased allergen levels, but a control group was not included in the study and clinical outcomes were not reported.57 These findings are consistent with those from a small laboratory study showing benefits from steam cleaning.58 British investigators found that high-efficiency vacuums reduced cat and dog allergen concentrations but not dust mite allergen concentrations. Patients showed improved pulmonary function and decreased β-agonist use.59 Several studies have demonstrated that repeated vacuuming can decrease mite levels, although these studies were of short duration and did not report clinical outcomes.60,61 A small study that compared 5 HEPA vacuums with 1 regular vacuum did not find any difference in exposure to mite allergen during vacuuming.62 Laboratory studies that examined the effect of 1-time vacuuming of carpet samples have yielded both positive and negative results.63,64 The vacuuming procedure may not have been intensive enough to show a benefit in the negative study.

Use of air cleaning devices

Evaluation of HEPA air filtration has yielded mixed results. A review by Wood65 concluded that HEPA filters may be effective for removing pet allergens, although studies were mixed and more evidence is needed. HEPA filters do not appear to be effective for reducing exposure to mites and mold. When used in uncarpeted rooms or in conjunction with HEPA vacuuming of carpeted rooms, HEPA air filters were effective in decreasing cat and dog allergens.6668

Evidence for improvements in clinical outcomes is less convincing. For example, a small, randomized, controlled trial examining the reduction of cat allergen by using HEPA air filtration, along with bedding encasements and cat exclusion, did not show a significant clinical effect.69 However, another small (n = 40), randomized trial of HEPA air filters showed a decline in airborne particulates and possible improvement in rhinitis or asthma symptoms and medication use among patients with sensitivity to dust mites.70 A study by van der Heide71 found that HEPA filters improved airways hyperesponsiveness but not symptoms among 20 children allergic to cats or dogs. Another study showed modest clinical benefits but no reduction in pet allergens.72 A comparison of vacuuming with vacuuming plus air filters found modest clinical benefits from the filters but no improvement in allergen exposure.66 A Cochrane review concluded that the evidence is insufficient to support or refute the effectiveness of air filters among people with pet allergies and exposure to pets.73

Moisture control through dehumidification

Ventilation and dehumidification to reduce humidity levels and exposure to mites have yielded mixed but generally positive results. In a national survey, the use of a dehumidifier was an independent predictor of lower levels of some asthma triggers and mold.74 Installation of whole-house mechanical ventilation can decrease humidity, decrease the number of mites, decrease mite allergen levels, and improve clinical outcomes.7577 Dehumidification in temperate climates with air-conditioners and dehumidifiers is effective in reducing mite levels.78 Ventilation and moisture control are typically related. Also, ventilation can decrease indoor contaminants, assuming that the outdoor air has lower levels of contaminants than the indoor air, which is not always the case if housing is located near point sources such as industrial emissions or near high-traffic roadways. In high-humidity climates, whole-house ventilation has been less effective.7981 Ventilation and air cleaners are considered further by Sandel et al82 in a companion article in this series.

Interventions in need of formative research

One-time professional cleaning

The panel identified 1-time professional cleaning as an intervention needing more formative efficacy research. Professional cleaning included removing clutter, washing hard surfaces, and vacuuming porous surfaces. Such cleaning is largely ineffective for lead hazard control purposes and has very short-lived effects.83 However, this cleaning may be more effective for biological contaminants if key elements of the cleaning process can be identified. For example, evidence shows that cleaning reduces cockroach allergen levels.44,84

No evidence/ineffective/harmful interventions

The panel found that 3 interventions—air cleaners that generate high levels of ozone, bedding encasement and/or sheet and/or upholstery cleaning alone, and acaricides (chemicals that reduce mite allergen levels) as single interventions—either had no evidence of effectiveness or were ineffective—and should not be used.

Air cleaners generating high levels of ozone

The panel found that air cleaners that generate high levels of ozone should not be used because of the association between ozone and asthma morbidity85 and because of the unknown benefits such devices have on removing indoor airborne particulate matter.6

Bedding encasement and/or sheet and/or upholstery cleaning alone

Studies that used single interventions—such as bedding encasements and/or sheet and/or upholstery cleaning—to control specific asthma triggers without the multifaceted approach described earlier either did not find benefit or tended to suffer from methodological deficiencies. The use of bedding encasements as isolated interventions to reduce exposure to mite allergen and improve asthma and allergy outcomes has been well studied. Two well-designed, large, randomized studies did not find improvements in clinical measures.86,87 Other earlier, smaller studies of bedding covers also did not find symptom benefits,88,89 although the study by van den Bemt et al88 observed improvement in morning peak flow. A study that evaluated efficacy of mattress covers, but had limited covariate data, showed no effect on clinical status.90

Studies that have attempted to prevent asthma incidence by reducing exposure to a single allergen (dust mite) have generally not been successful. For example, 2 studies employed multiple mite control measures among high-risk children. The Child Asthma Prevention Study, a well-designed trial that assessed the impact of bedding encasements and bed linen washing with acaracide solution, did not show reduced asthma, wheeze, or atopy incidence.91,92 Another multicomponent study using allergen-impermeable covers for the maternal and child beds, an allergen-impermeable cot/carrycot mattress, a high-filtration vacuum cleaner, vinyl flooring in the child's bedroom, bed linen that was hot-washed weekly, and a washable soft toy showed increased mite sensitization in the intervention group but better lung function (specific airway resistance) at age 3 years.93 A study that employed aggressive and multiple interventions for mites (tannic acid, bedding encasements, and laundry service) showed decreased exposure and improved airways hyperresponsiveness but did not affect forced expiratory volume in the first second of expiration (a measure of lung function), symptoms, or quality of life.94

Acaricides as a single intervention

The panel found that acaricides used as a single intervention do not appear to be effective. A study of treating carpets with chemicals (tannic acid and benzyl benzoate) showed reduced mite allergen concentration, but effects were not seen in all treated carpets and were not long-lasting.95 In addition, certain carpet treatments can interfere with immunoassay measurement of allergens, which questions the validity of studies that used this outcome measure.95,96 A meta-analysis of 23 studies that focused on dust mite control with acaricides found no effect.97


The panel concluded that some interventions are effective in reducing exposure to indoor biologic agents that can cause asthma symptoms among people with asthma. In particular, sufficient evidence supports the widespread dissemination of multifaceted, in-home, tailored interventions for asthma; IPM for reducing cockroach allergen; and combined elimination of moisture intrusion and leaks and removal of moldy items to reduce respiratory symptoms. An important limitation of these conclusions is that the effectiveness of interventions may vary by region (due to variability in climate and predominant types of housing) and tailoring to local conditions may be important. Another caveat is that even the strongest housing interventions will be hampered in their ability to reduce asthma morbidity if individuals residing in those houses are exposed to other indoor and outdoor pollutants, such as environmental tobacco smoke and ozone.


1. Centers for Disease Control and Prevention. National surveillance for asthma—United States, 1980-2004. MMWR Morb Mortal Wkly Rep. 2007; 56(SS8):1–14–54, 18–54.
2. von Mutius E. Gene-environment interactions in asthma. J Allergy Clin Immunol. 2009; 123(1):3–11.
3. Miller RL. Breathing freely: the need for asthma research on gene-environment interactions. Am J Public Health. 1999; 89(6):819–822.
4. Institute of Medicine. Clearing the Air: Asthma and Indoor Air Exposures. Washington, DC: National Academies Press; 2000.
5. Krieger JW, Takaro TK, Song L, Weaver M. The Seattle-King County Healthy Homes Project: a randomized, controlled trial of a community health worker intervention to decrease exposure to indoor asthma triggers. Am J Public Health. 2005; 95(4):652–659.
6. Diette GB, McCormack MC, Hansel NN, Breysse PN, Matsui EC. Environmental issues in managing asthma. Respir Care. 2008; 53(5):602–615–617; discussion 616–617.
7. Dales R, Liu L, Wheeler AJ, Gilbert NL. Quality of indoor residential air and health. Can Med Assoc J. 2008; 179(2):147–152.
8. Ogg B, Ferraro D, Ogg O. Cockroach Control Manual. Lincoln, NE: University of Nebraska-Lincoln; 1995:1–91.
9. Custovic A, Chapman M. Risk levels for mite allergens. Are they meaningful? Allergy. 1998; 53(suppl 48):71–76.
10. Huss K, Adkinson NF Jr, Eggleston PA, Dawson C, Van Natta ML, Hamilton RG. House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program. J Allergy Clin Immunol. 2001; 107(1):48–54.
11. Arbes SJ Jr, Cohn RD, Yin M, et al. House dust mite allergen in US beds: results from the First National Survey of Lead and Allergens in Housing. J Allergy Clin Immunol. 2003; 111(2):408–414.
12. Chew G, Perzanowski M, Canfield S, et al. Cockroach allergen levels and associations with cockroach-specific IgE. J Allergy Clin Immunol. 2008; 121(1):240–245.
13. Rauh VA, Chew GL, Garfinkel RS. Deteriorated housing contributes to high cockroach allergen levels in inner-city households. Environ Health Perspect. 2002; 110(2):323–327.
14. Rosenstreich DL, Eggleston P, Kattan M, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med. 1997; 336(19):1356–1363.
15. Eggleston PA, Arruda LK. Ecology and elimination of cockroaches and allergens in the home. J Allergy Clin Immunol. 2001; 107(suppl 3):S422–S429.
16. Cohn RD, Arbes SJ Jr, Jaramillo R, Reid LH, Zeldin DC. National prevalence and exposure risk for cockroach allergen in US households. Environ Health Perspect. 2006; 114(4):522–526.
17. Salo PM, Arbes SJ, Crockett PW, et al. Exposure to multiple indoor allergens in US homes and its relationship to asthma. J Allergy Clin Immunol. 2008; 121:678–684.
18. Institute of Medicine. Damp Indoor Spaces and Health. Washington, DC: National Academies Press; 2004.
19. Health Canada. Fungal Contamination in Public Buildings: Health Effects and Investigation Methods. Ottawa, Ontario, Canada: Health Canada; 2004. http://www.hc-sc.gc.ca/ewh-semt/alt_formats/hecs-sesc/pdf/pubs/air/fungal-fongique/fungal-fongique-eng.pdf. Accessed November 4, 2009.
20. Hollander A, Heederik D, Doekes G, Kromhout H. Determinants of airborne rat and mouse urinary allergen exposure. Scand J Work Environ Health. 1998; 24(3):228–235.
21. Lieutier-Colas F, Meyer P, Pons F, et al. Prevalence of symptoms, sensitization to rats, and airborne exposure to major rat allergen (Rat n 1) and to endotoxin in rat-exposed workers: a cross-sectional study. Clin Exp Allergy. 2002; 32(10):1424–1429.
22. Ohman JL, Hagberg K, MacDonald MR, et al. Distribution of airborne mouse allergen in a major breeding facility. J Allergy Clin Immunol. 1994; 94:810–817.
23. Phipatanakul W. Rodent allergens. Curr Allergy Asthma Rep. 2002; 2(5):412–416.
24. Cohn RD, Arbes SJ Jr, Yin M, Jaramillo R, Zeldin DC. National prevalence and exposure risk for mouse allergen in US households. J Allergy Clin Immunol. 2004; 113(6):1167–1171.
25. Phipatanakul W, Eggleston PA, Wright EC, Wood RA. Mouse allergen, part I: the prevalence of mouse allergen in inner-city homes. The National Cooperative Inner-City Asthma Study. J Allergy Clin Immunol. 2000; 106(6):1070–1074.
26. Chew GL, Perzanowski MS, Miller RL, et al. Distribution and determinants of mouse allergen exposure in low-income New York City apartments. Environ Health Perspect. 2003;2003(10):1348–1351.
27. Jacobs DE, Brown MJ, Baeder A, et al. A systematic review of housing interventions and health: introduction methods, and summary findings. J Public Health Manag Pract. 2010; 16(5S):S5–S10.
28. Briss PA, Zaza S, Pappaioanou M, et al. Developing an evidence-based guide to community preventive services-methods. Am J Prev Med. 2000; 18(1)(suppl):35–43.
29. Carter MC, Perzanowski MS, Raymond A, Platts-Mills TAE. Home intervention in the treatment of asthma among inner-city children. J Allergy Clin Immunol. 2001; 108(5):732–737.
30. Eggleston PA, Butz A, Rand C, et al. Home environmental intervention in inner-city asthma: a randomized controlled clinical trial. Ann Allergy Asthma Immunol. 2005; 95(6):518–524.
31. Morgan WJ, Crain EF, Gruchalla RS, et al. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med. 2004; 351(11):1068–1080.
32. Levy JI, Brugge D, Peters JL, Clougherty JE, Saddler SS. A community-based participatory research study of multifaceted in-home environmental interventions for pediatric asthmatics in public housing. Soc Sci Med. 2006; 63(8):2191–2203.
33. Williams SG, Brown CM, Falter KH, et al. Does a multifaceted environmental intervention alter the impact of asthma on inner-city children? J Natl Med Assoc. 2006; 98(2):249–260.
34. Becker A, Watson W, Ferguson A, Dimich-Ward H, Chan-Yeung M. The Canadian Asthma Primary Prevention Study: outcomes at 2 years of age. J Allergy Clin Immunol. 2004; 113(4):650–656.
35. Schonberger H, Dompeling E, Knottnerus JA, et al. The PREVASC study: the clinical effect of a multifaceted educational intervention to prevent childhood asthma. Eur Respir J. 2005; 25(4):660–670.
36. Maas T, Kaper J, Sheikh A, et al. Mono and multifaceted inhalant and/or food allergen reduction interventions for preventing asthma in children at high risk of developing asthma. Cochrane Database Syst Rev. 2009; 3:CD006480.
37. Crocker D, Hopkins D, Kinyota S, et al. Home-based interventions to reduce asthma morbidity and mortality. Paper presented at: The Task Force on Community Preventive Services; 2008; Atlanta, GA.
38. Parker EA, Israel BA, Robins TG, et al. Evaluation of community action against asthma: a community health worker intervention to improve children's asthma-related health by reducing household environmental triggers for asthma. Health Educ Behav. 2008; 35(3):376–395.
39. Krieger J, Takaro TK, Song L, Beaudet N, Edwards K. The Seattle-King County Healthy Homes II Project: a randomized controlled trial of asthma self-management support comparing clinic-based nurses and in-home community health workers. Arch Pediatr Adolesc Med. 2009; 163(2):141–149.
40. Williams MK, Barr DB, Camann DE, et al. An intervention to reduce residential insecticide exposure during pregnancy among an inner-city cohort. Environ Health Perspect. 2006; 114(11):1684–1689.
41. Wang CL, Bennett GW. Comparative study of integrated pest management and baiting for German cockroach management in public housing. J Econ Entomol. 2006; 99(3):879–885.
42. Miller DM, Meek F. Cost and efficacy comparison of integrated pest management strategies with monthly spray insecticide applications for German cockroach (Dictyoptera: Blattellidae) control in public housing. J Econ Entomol. 2004;2004(2):559–569.
43. Arbes SJ, Sever M, Archer J, et al. Abatement of cockroach allergen (Bla g 1) in low-income, urban housing: a randomized controlled trial. J Allergy Clin Immunol. 2003; 112(2):339–345.
44. McConnell R, Jones C, Milam J, et al. Cockroach counts and house dust allergen concentrations after professional cockroach control and cleaning. Ann Allergy Asthma Immunol. 2003; 91(6):546–552.
45. Klitzman S, Caravanos J, Belanoff C, Rothenberg L. A multihazard, multistrategy approach to home remediation: results of a pilot study. Environ Res. 2005; 99(3):294–306.
46. Sever ML, Arbes SJ, Gore JC, et al. Cockroach allergen reduction by cockroach control alone in low-income urban homes: a randomized control trial. J Allergy Clin Immunol. 2007; 120:849–855.
47. Phipatanakul W, Cronin B, Wood RA, et al. Effect of environmental intervention on mouse allergen levels in homes of inner-city Boston children with asthma. Ann Allergy Asthma Immunol. 2004; 92(4):420–425.
48. New York City Department of Health and Mental Hygiene. Guidelines on assessment and remediation of fungi in indoor environments. http://www.nyc.gov/html/doh/html/epi/moldrpt1.shtml. Published November 2008. Accessed December 8, 2009.
49. World Health Organization. WHO Guidelines for Indoor Air Quality Dampness and Mould. Copenhagen, Denmark: WHO Regional Office for Europe; 2009. http://www.euro.who.int/document/E92645.pdf. Accessed December 3, 2009.
50. Husman TM. The Health Protection Act, National Guidelines for Indoor Air Quality and Development of the National Indoor Air Programs in Finland. Environ Health Perspect. 1999; 107(suppl 3):515–517.
51. Burr ML, Matthews IP, Arthur RA, et al. Effects on patients with asthma of eradicating visible indoor mould: a randomised controlled trial. Thorax. 2007; 62(9):766–771.
52. Kercsmar CM, Dearborn DG, Schluchter M, et al. Reduction in asthma morbidity in children as a result of home remediation aimed at moisture sources. Environ Health Perspect. 2006; 114(10):1574–1580.
53. Rockwell W. Prompt remediation of water intrusion corrects the resultant mold contamination in a home. Allergy Asthma Proc. 2005; 26(4):316–318.
54. Lignell U, Meklin T, Putus T, et al. Effects of moisture damage and renovation on microbial conditions and pupils' health in two schools: a longitudinal analysis of five years. J Environ Monit. 2007; 9(3):225–233.
55. Chew GL, Wilson J, Rabito FA, et al. Mold and endotoxin levels in the aftermath of Hurricane Katrina: a pilot project of homes in New Orleans undergoing renovation. Environ Health Perspect. 2006; 114(12):1883–1889.
56. Howden-Chapman P, Matheson A, Crane J, et al. Effect of insulating existing houses on health inequality: cluster randomised study in the community. BMJ. 2007; 334(7591):460–464.
57. Vojta PJ, Randels SP, Stout J, et al. Effects of physical interventions on house dust mite allergen levels in carpet, bed, and upholstery dust in low-income, urban homes. Environ Health Perspect. 2001; 109(8):815–819.
58. Colloff MJ, Taylor C, Merrett TG. The use of domestic steam cleaning for the control of house-dust mites. Clin Exp Allergy. 1995; 25(11):1061–1066.
59. Popplewell EJ, Innes VA, Lloyd-Hughes S, et al. The effect of high-efficiency and standard vacuum-cleaners on mite, cat and dog allergen levels and clinical progress. Pediatr Allergy Immunol. 2000; 11(3):142–148.
60. Adilah N, Fitzharris P, Crane J, Siebers RW. The effect of frequent vacuum cleaning on the house dust mite allergen, Der p 1 in carpets: a pilot study. N Z Med J. 1997; 110 (1056):438–439.
61. Munir AK, Einarsson R, Dreborg SK. Vacuum cleaning decreases the levels of mite allergens in house dust. Pediatr Allergy Immunol. 1993; 4(3):136–143.
62. Gore RB, Durrell B, Bishop S, et al. High-efficiency vacuum cleaners increase personal mite allergen exposure, but only slightly. Allergy. 2006; 61(1):119–123.
63. Sercombe JK, Liu-Brennan D, Causer SM, Tovey ER. The vertical distribution of house dust mite allergen in carpet and the effect of dry vacuum cleaning. Int J Hyg Environ Health. 2007; 210(1):43–50.
64. Roberts JW, Clifford WS, Glass G, Hummer PG. Reducing dust, lead, dust mites, bacteria, and fungi in carpets by vacuuming. Arch Environ Contam Toxicol. 1999; 36(4):477–484.
65. Wood RA. Air filtration devices in the control of indoor allergens. Curr Allergy Asthma Rep. 2002; 2(5):397–400.
66. Green R, Simpson A, Custovic A, et al. The effect of air filtration on airborne dog allergen. Allergy. 1999; 54(5):484–488.
67. de Blay F, Chapman MD, Platts-Mills TA. Airborne cat allergen (Fel d I): environmental control with the cat in situ. Am Rev Respir Dis. 1991; 143(6):1334–1339.
68. Custovic A, Simpson A, Pahdi H, et al. Distribution, aerodynamic characteristics, and removal of the major cat allergen Fel d 1 in British homes. Thorax. 1998; 53(1):33–38.
69. Wood RA, Johnson EF, van Natta ML, Chen PH, Eggleston PA. A placebo-controlled trial of a HEPA air cleaner in the treatment of cat allergy. Am J Respir Crit Care Med. 1998; 158(1):115–120.
70. Reisman RE, Mauriello PM, Davis GB, Georgitis JW, Demasi JM. A double-blind-study of the effectiveness of a high-efficiency particulate air (HEPA) filter in the treatment of patients with perennial allergic rhinitis and asthma. J Allergy Clin Immunol. 1990; 85(6):1050–1057.
71. van der Heide S, van Aalderen WMC, Kauffman HF, Dubois AEJ, de Monchy JGR. Clinical effects of air cleaners in homes of asthmatic children sensitized to pet allergens. J Allergy Clin Immunol. 1999; 104(2):447–451.
72. Francis H, Fletcher G, Anthony C, et al. Clinical effects of air filters in homes of asthmatic adults sensitized and exposed to pet allergens. Clin Exp Allergy. 2003; 33(1):101–105.
73. Kilburn S, Lasserson TJ, McKean M. Pet allergen control measures for allergic asthma in children and adults. Cochrane Database Syst Rev. 2003;(1):CD002989.
74. Salo PM, Yin M, Arbes SJ, et al. Dustborne Alternaria alternata antigens in US homes: results from the national survey of lead and allergens. J Allergy Clin Immunol. 2005; 116(3):623–629.
75. Warner JA, Frederick JM, Bryant TN, et al. Mechanical ventilation and high-efficiency vacuum cleaning: a combined strategy of mite and mite allergen reduction in the control of mite-sensitive asthma. J Allergy Clin Immunol. 2000; 105(1):75–82.
76. Harving H, Korsgaard J, Dahl R. Clinical efficacy of reduction in house-dust mite exposure in specially designed, mechanically ventilated “healthy” homes. Allergy. 1994; 49(10):866–870.
77. Harving H, Korsgaard J, Dahl R. House-dust mite exposure reduction in specially designed, mechanically ventilated “healthy” homes. Allergy. 1994; 49(9):713–718.
78. Arlian L, Neal J, Morgan M, et al. Reducing relative humidity is a practical way to control dust mites and their allergens in homes in temperate climates. J Allergy Clin Immunol. 2001; 107(1):99–104.
79. Fletcher AM, Pickering CA, Custovic A, et al. Reduction in humidity as a method of controlling mites and mite allergens: the use of mechanical ventilation in British domestic dwellings. Clin Exp Allergy. 1996; 26(9):1051–1056.
80. Niven R, Fletcher AM, Pickering AC, et al. Attempting to control mite allergens with mechanical ventilation and dehumidification in British houses. J Allergy Clin Immunol. 1999; 103(5, pt 1):756–762.
    81. Crane J, Ellis I, Siebers R, et al. A pilot study of the effect of mechanical ventilation and heat exchange on house-dust mites and Der p 1 in New Zealand homes. Allergy. 1998; 53(8):755–762.
    82. Sandel M, Baeder A, Bradman A, et al. Housing interventions and control of health-related chemical agents: a review of the evidence. J Public Health Manag Pract. 2010; 16(5S):S24–S33.
    83. Tohn ER, Dixon SL, Wilson JW, Galke WA, Clark CS. An evaluation of one-time professional cleaning in homes with lead-based paint hazards. Appl Occup Environ Hyg. 2003; 18(2):138–143.
    84. Arbes SJ Jr, Sever M, Mehta J, et al. Abatement of cockroach allergens (Bla g 1 and Bla g 2) in low-income, urban housing: month 12 continuation results. J Allergy Clin Immunol. 2004; 113(1):109–114.
    85. Trasande L, Thurston GD. The role of air pollution in asthma and other pediatric morbidities. J Allergy Clin Immunol. 2005; 115(4):689–699.
    86. Terreehorst I, Hak E, Oosting AJ, et al. Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N Engl J Med. 2003; 349(3):237–246.
    87. Woodcock A, Forster L, Matthews E, et al. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. N Engl J Med. 2003; 349(3):225–236.
    88. van den Bemt L, van Knapen L, de Vries MP, et al. Clinical effectiveness of a mite allergen-impermeable bed-covering system in asthmatic mite-sensitive patients. J Allergy Clin Immunol. 2004; 114(4):858–862.
    89. Luczynska C, Tredwell E, Smeeton N, Burney P. A randomized controlled trial of mite allergen-impermeable bed covers in adult mite-sensitized asthmatics. Clin Exp Allergy. 2003; 33(12):1648–1653.
    90. Rijssenbeek-Nouwens LHM, Oosting AJ, de Bruin-Weller MS, et al. Clinical evaluation of the effect of anti-allergic mattress covers in patients with moderate to severe asthma and house dust mite allergy: a randomised double blind placebo controlled study. Thorax. 2002; 57(9):784–790.
    91. Marks GB, Mihrshahi S, Kemp AS, et al. Prevention of asthma during the first 5 years of life: a randomized controlled trial. J Allergy Clin Immunol. 2006; 118(1):53–61.
    92. Mihrshahi S, Marks GB, Criss S, et al. Effectiveness of an intervention to reduce house dust mite allergen levels in children's beds. Allergy. 2003; 58(8):784–789.
    93. Woodcock A, Lowe LA, Murray CS, et al. Early life environmental control: effect on symptoms, sensitization, and lung function at age 3 years. Am J Respir Crit Care Med. 2004;2004(4):433–439.
    94. Shapiro GG, Wighton TG, Chinn T, et al. House dust mite avoidance for children with asthma in homes of low-income families. J Allergy Clin Immunol. 1999; 103(6):1069–1074.
    95. Woodfolk JA, Hayden ML, Couture N, Platts-Mills TAE. Chemical treatment of carpets to reduce allergen: comparison of the effects of tannic-acid and other treatments on proteins derived from dust mites and cats. J Allergy Clin Immunol. 1995; 96(3):325–333.
    96. Chew GL, Higgins KM, Milton DK, Burge HA. The effects of carpet fresheners on the behaviour of indoor allergen assays. Clin Exp Allergy. 1999; 29:470–477.
    97. Gotzsche PC, Hammarquist C, Burr M. House dust mite control measures in the management of asthma: meta-analysis. BMJ. 1998; 317(7166):1105–1110.

    allergens; asthma; cockroaches; dust; housing; mice; mites; moisture; prevention; rats

    © 2010 Lippincott Williams & Wilkins, Inc.